• Nenhum resultado encontrado

[PDF] Top 20 Pharmacoeconomic studies in Brazil: where are we?

Has 10000 "Pharmacoeconomic studies in Brazil: where are we?" found on our website. Below are the top 20 most common "Pharmacoeconomic studies in Brazil: where are we?".

Pharmacoeconomic studies in Brazil: where are we?

Pharmacoeconomic studies in Brazil: where are we?

... Os resultados desta revisão apontam para a necessidade da expansão de estudos que possam contribuir para melhores decisões alocativas dos investimentos oriundos dos serviços de saúde, [r] ... See full document

6

ONLINE DISPUTE RESOLUTION IN BRAZIL: ARE WE READY FOR THIS CULTURAL TURN?

ONLINE DISPUTE RESOLUTION IN BRAZIL: ARE WE READY FOR THIS CULTURAL TURN?

... and in particular, based on the power of computers to efficiently process enormous amounts of data, store and organize such data and communicate it across the internet on a global basis and with ...However, ... See full document

13

Work engagement. What do we know and where do we go?

Work engagement. What do we know and where do we go?

... Previous studies have consistently shown that job resources and personal resources are positively associated with work engagement (for recent overviews see: Christian, Garza & Slaughter, 2011; ... See full document

8

Mesenchymal stromal cells’ therapy for polyglutamine disorders: where do we stand and where should we go?

Mesenchymal stromal cells’ therapy for polyglutamine disorders: where do we stand and where should we go?

... both in pre-clinic and clinic grades, in 2016 ISCT issued a position statement urging the need to identify MSC functional markers of potency and implement assays for the measurement of such ...help ... See full document

25

HOW DO WE IDENTIFY MICRONYCTERIS (SCHIZONYCETRIS) SANBORNI SIMMONS, 1996 (CHIROPTERA, PHYLLOSTOMIDAE) RELIABLY AND WHERE WE CAN FIND THIS SPECIES IN BRAZIL?

HOW DO WE IDENTIFY MICRONYCTERIS (SCHIZONYCETRIS) SANBORNI SIMMONS, 1996 (CHIROPTERA, PHYLLOSTOMIDAE) RELIABLY AND WHERE WE CAN FIND THIS SPECIES IN BRAZIL?

... distributed in the dry forests of South America, but is known from only few ...localities are presented for M. sanborni, and are analyzed together with those available in the literature, ... See full document

12

Natural orifice transluminal endoscopic surgery (NOTES): where are we going? A bibliometric assessment.

Natural orifice transluminal endoscopic surgery (NOTES): where are we going? A bibliometric assessment.

... increase in the number of randomised controlled trials ...increase in the number of colorectal procedures and nephrectomies (P = ...investigation in the field of NOTES-assisted techniques (P = ... See full document

6

Trends in the discovery of new marine natural products from invertebrates over the last two decades - where and what are we bioprospecting?

Trends in the discovery of new marine natural products from invertebrates over the last two decades - where and what are we bioprospecting?

... NMNPI in polar regions. Although sponges are commonly designated as the dominant macroinvertebrates in many Antarctic benthic commu- nities [44,62], results reveal that echinoderms have been a more ... See full document

15

Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next

Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next

... The current knowledge on the pathogenesis of DISH is very limited. Some of the pathogenic pathways have been adopted from analogous entities such as ossifica- tion of the posterior longitudinal ligament (OPLL). The main ... See full document

6

Antibiotic discovery: where have we come from, where do we go?

Antibiotic discovery: where have we come from, where do we go?

... 76%) in predicting differentially expressed ...role in microbial responses to antibiotics, and therefore can be an alternative for new antimicrobial targets and/or novel combinatorial therapies [ 103 ... See full document

21

Schistosomiasis epidemiology and control: how did we get here and where should we go?

Schistosomiasis epidemiology and control: how did we get here and where should we go?

... scientific studies of schistosomiasis began only 150 years ...was, in the light of experience and cost, gradually replaced by less ambitious targets; first to stop transmission and then to reduce ... See full document

12

Treatment of knee OSTEOARTHRITIS in Spa Health resorts: where do we stand?

Treatment of knee OSTEOARTHRITIS in Spa Health resorts: where do we stand?

... increase in plasma leptin after 2 weeks of spa therapy, with no evident correlation with parameters of clinical efficacy (VAS, Lequesne ...decrease in adiponectin after spa therapy was found; this may play ... See full document

11

Epidemiology of osteoporotic fractures in Brazil: what we have and what we need

Epidemiology of osteoporotic fractures in Brazil: what we have and what we need

... differences in the population and utilization of public healthcare ...200 studies about osteoporosis and fractures have been conducted in Brazil, among whi- ch 60 have described the current ... See full document

7

View of stakeholders on GMOs in Brazil: where we are now? - Portal Embrapa

View of stakeholders on GMOs in Brazil: where we are now? - Portal Embrapa

... The results obtained by the ACM are described below: Dimension 1 28% of the total inertia: the categories that most assist in classifying this dimension are: a positive or negative attit[r] ... See full document

23

Entrepreneurial journalism education: where are we now?

Entrepreneurial journalism education: where are we now?

... mentioned are internships with journalism entrepreneurs; specialized simulation games (Kelly Toughill: “I wish we had a simulation game similar to CAPSIM (which is?)that could be used as the basis for an ... See full document

27

Cognitive culture studies : where science meets the humanities

Cognitive culture studies : where science meets the humanities

... especially in business and administration ...authors in this area is Geert Hofstede with his famous books on – quoting a recent title – “Cultures and Or- ...2005). We are of course not ... See full document

10

Patient experience in home respiratory therapies : where we are and where to go

Patient experience in home respiratory therapies : where we are and where to go

... gap, we need to be aware of the current methods being used to assess the patient ...healthcare are available and described in this ...and, in some cases, by carers of children. In our ... See full document

24

Ebola… How far away are we?

Ebola… How far away are we?

... “Outbreak”, in which Dustin Hoffman and Rene Russo worked to stop a fictional virus similar to ...Ebola. In the movie the virus is introduced from Africa to the US by a ...monkey. In another film, ... See full document

4

NOD2 mutations and colorectal cancer - Where do we stand?

NOD2 mutations and colorectal cancer - Where do we stand?

... population-based studies, and despite initial inconsistencies, recent data points to an important role for NOD2 mutations in CRC ...included in stricter CRC surveillance ... See full document

11

Where are aphasia theory and management “headed”?

Where are aphasia theory and management “headed”?

... resulting in Broca’s aphasia with non-fluent, halting ver- bal output and the inferior division of the left MCA supplying brain regions resulting in Wernicke’s aphasia with fluent, verbose, low-content ... See full document

8

Pragmatic studies in Brazil.

Pragmatic studies in Brazil.

... Enquanto para Orlandi (1996: 33) há uma “diferença fundamental” entre a pragmática e a análise de discurso, diferença esta que estaria ligada à “própria noção de discurso”, na ótica de P[r] ... See full document

16

Show all 10000 documents...